首页 > SAT练习 > OG详解 > OG9 > 详情
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
题目来源:

OG9 阅读 Q47

正确答案:C
题目详解
反馈
Choice C is the best answer. In the first sentence of the last paragraph of Passage 2, the author expresses reservations about the immediate usefulness of teixobactin: "So, what are my caveats? Well, I see three. First, teixobactin isn't a potential panacea. . . . Secondly, scaling to commercial manufacture will be challenging. . . . And, thirdly . . . teixobactin now faces the long haul of clinical trials." The author uses the word "caveats" to introduce skeptical comments about teixobactin's value. Thus, the word "caveats," as used in the first sentence of the last paragraph of Passage 2, most nearly means misgivings.
Choices A, B, and D are incorrect because in the context of the passage, "caveats" means misgivings, not exceptions (choice A), restrictions (choice B), or explanations (choice D).
0
题目标记:
答对了
答错了
漏选了
收藏
讨论

注:题目来源来自网络

选择你收藏的理由
发送
取消
发表评论
发送

  • 回复
  • 复制
  • 删除

取消